
Response Questions for Teleconference Email, July 12, 2010 - Anascorp


 

 
Our responses to your questions for July 15 teleconFrom: -----(b)(4)-------
-----(b)(4)-------
Sent: Monday, July 12, 2010 7:13 PM
To: Cordaro, Debbie
Subject: RE: Our responses to your questions for July 15 telecon

Hi Debbie:
Thanks very much for the Agency’s responses.  We have looked them over and still 
would like to talk with the Agency.
Thanks for your help and quick response.
(b)(4)
 
-------(b)(4)---------
-(b)(4)-
-----(b)(4)-------
-----(b)(4)-------
-----(b)(4)-------
-----(b)(4)-------
-----(b)(4)-------
 


From: Cordaro, Debbie [mailto:Debbie.Cordaro@fda.hhs.gov] 
Sent: Monday, July 12, 2010 2:18 PM
To: ----(b)(4)----
Cc: ----(b)(4)----
Subject: Our responses to your questions for July 15 telecon
 
<<Bioclon CRMTS 7517 Meeting Responses Fax.pdf>> 
Hi (b)(4), 
FDA is providing their responses to the questions you posed for our meeting 
Thursday.  Please let me know your decision regarding changing the agenda.
Have a nice day, 
Debbie 
 
Debbie Cordaro 
Debbie Cordaro 
Regulatory Project Manager 
OBRR 
Voice: 301-827-6157 Fax 301-827-2857 
debbie.cordaro@fda.hhs.gov

 

__________ Information from ESET NOD32 Antivirus, version of virus signature 
database 5273 (20100712) __________

The message was checked by ESET NOD32 Antivirus.

http://www.eset.com/


__________ Information from ESET NOD32 Antivirus, version of virus signature 
database 5273 (20100712) __________

The message was checked by ESET NOD32 Antivirus.

http://www.eset.com/
